Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

75.35
-1.9700-2.55%
Post-market: 75.350.00000.00%19:39 EDT
Volume:379.16K
Turnover:28.69M
Market Cap:1.73B
PE:16.60
High:77.81
Open:77.33
Low:74.81
Close:77.32
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.41
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.90
PE(LYR):22.70

Loading ...

Buzz-ani Pharma's Eye Implant Meets Main Goals in Eye Disease Trial

Reuters
·
Jul 13

ANI Says Phase 4 Chronic Non-Infectious Uveitis Trial Met Primary Endpoints

MT Newswires Live
·
Jul 13

ANI Pharmaceuticals Announces Positive Six-month Topline Data from the Phase 4 Open-label, Single-arm Synchronicity Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-infectious Uveitis

THOMSON REUTERS
·
Jul 13

ANI Pharmaceuticals - Synchronicity Trial Meets Both Co-primary Endpoints at 6 Months

THOMSON REUTERS
·
Jul 13

ANI Pharmaceuticals (ANIP) Recalls HydrOXYzine Solution, Is The Pullback A Valuation Opportunity?

Simply Wall St.
·
Jul 11

ANI Pharmaceuticals Price Target Maintained with a $124.00/share by Guggenheim

Dow Jones
·
Jul 10

ANI Pharma SVP, CFO Stephen P. Carey Disposes of 3,313 Common Shares Worth $284,918

Reuters
·
Jul 07

ANI Pharma SVP, CFO Stephen P. Carey Disposes of 2,850 Shares for $239,742‬

Reuters
·
Jul 01

ANI Pharma Sr. VP, General Counsel Meredith Cook sells 500 common shares worth $41,015

Reuters
·
Jun 16

ANI Pharmaceuticals director Thomas Haughey disposes of 2,000 shares for $161,760

Reuters
·
Jun 11

ANI Pharma SVP, CFO Stephen P. Carey disposes of 3,312 common shares for $264,960

Reuters
·
Jun 10

A Look At ANI Pharmaceuticals (ANIP) Valuation As Shares Trade Below Popular Fair Value Estimate

Simply Wall St.
·
Jun 03

ANI Pharmaceuticals Signals Confident 2026 Growth Path

TIPRANKS
·
Jun 02

ANI Pharma CEO Lalwani to speak at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 27

ANI Pharmaceuticals shareholders approve amended 2022 stock incentive plan at annual meeting

Reuters
·
May 22

ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays

TIPRANKS
·
May 20

Emmaus Life Sciences Q1 FY26 net loss widens to $3.3 million; net revenues fall 18% to $2 million

Reuters
·
May 16

Top Executives Quietly Unload a Wave of ANI Pharmaceuticals Shares

TIPRANKS
·
May 14

ANI Pharma director Patrick D. Walsh disposes common shares worth $1.13 million

Reuters
·
May 14

ANI Pharma CEO Nikhil Lalwani sells 55,000 shares for $4.27 million

Reuters
·
May 14